NP47923a Adalimumab
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Framework (Supply)
- Duration
- 23.5 month (est.)
- Value
- £45M
- Sector
- HEALTH
- Published
- 07 Feb 2024
- Delivery
- To 27 Jan 2026 (est.)
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
Geochart for 2 buyers and 6 suppliers
2 buyers
- NHS National Services Scotland NSS Edinburgh
6 suppliers
- Abbvie Maidenhead
- Amgen Cambridge
- Biogen Idec Maidenhead
- Celltrion Healthcare Slough
- Fresenius Kabi Runcorn
- Sandoz Surrey
Description
Supply of adalimumab to NHS Scotland.
Total Quantity or Scope
Supply of Adalimumab pre-filled pens/devices and pre-filled syringes to NHS Scotland. The Authority has awarded this framework as an unranked multi-supplier framework per product line to six (6) Framework Participants.
Award Detail
1 | Abbvie (Maidenhead)
|
2 | Amgen (Cambridge)
|
3 | Biogen Idec (Maidenhead)
|
4 | Celltrion Healthcare (Slough)
|
5 | Fresenius Kabi (Runcorn)
|
6 | Sandoz (Surrey)
|
Award Criteria
API Sources | 5.0 |
PRICE | 95.0 |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Award on basis of price.
Other Information
The estimated values referred to in Section II.1.5 covers the initial duration of the framework and the stated extension period of the framework. (SC Ref:756866)
Reference
- FTS 003970-2024